Outcomes of severe sepsis and septic shock patients after stratification by initial lactate value
- PMID: 29576823
- PMCID: PMC5847496
- DOI: 10.5847/wjem.j.1920-8642.2018.02.005
Outcomes of severe sepsis and septic shock patients after stratification by initial lactate value
Abstract
Background: In the setting of severe sepsis and septic shock, mortality increases when lactate levels are ≥ 4 mmol/L. However, the consequences of lower lactate levels in this population are not well understood. The study aimed to determine the in-hospital mortality associated with severe sepsis and septic shock when initial lactate levels are < 4 mmol/L.
Methods: This is a retrospective cohort study of septic patients admitted over a 40-month period. Totally 338 patients were divided into three groups based on initial lactate values. Group 1 had lactate levels < 2 mmol/L; group 2: 2-4 mmol/L; and group 3: ≥ 4 mmol/L. The primary outcome was in-hospital mortality.
Results: There were 111 patients in group 1, 96 patients in group 2, and 131 in group 3. The mortality rates were 21.6%, 35.4%, and 51.9% respectively. Univariate analysis revealed the mortality differences to be statistically significant. Multivariate logistic regression demonstrated higher odds of death with higher lactate tier group, however the findings did not reach statistical significance.
Conclusion: This study found that only assignment to group 3, initial lactic acid level of ≥ 4 mmol/L, was independently associated with increased mortality after correcting for underlying severity of illness and organ dysfunction. However, rising lactate levels in the other two groups were associated with increased severity of illness and were inversely proportional to prognosis.
Keywords: Emergency medicine; Lactic acid; Sepsis.
Conflict of interest statement
Conflicts of interest: None of the authors have any conflicts of interest as it pertains to this work. PD receives grant funding, which goes to his institution, from Vapotherm Inc.
Figures
References
-
- Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al. Nationwide Trends of Severe Sepsis in the 21st Century (2000-2007) Chest. 2011;140(5):1223–31. - PubMed
-
- Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the Incidence and Mortality of Severe Sepsis in the United States. Crit Care Med. 2013;41(5):1167–74. - PubMed
-
- Tiru B, DiNino EK, Orenstein A, Mailloux PT, Pesaturo A, Gupta A, et al. The economic and humanistic burden of severe sepsis. Pharmacoeconomics. 2015;33(9):925–37. - PubMed
-
- Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources